Please login to the form below

Not currently logged in
Email:
Password:

Intra-Cellular Therapeutics

This page shows the latest Intra-Cellular Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Intra-Cellular soars on FDA approval of schizophrenia drug

Intra-Cellular soars on FDA approval of schizophrenia drug

Shares rocketed following the announcement. US biotech Intra-Cellular Therapeutics has scored approval for its antipsychotic drug Caplyta for the treatment of schizophrenia, to the delight of investors. . ... The approval is an early Christmas present

Latest news

  • Intra-Cellular plans schizophrenia filing in 2018 Intra-Cellular plans schizophrenia filing in 2018

    Says lumateperone could provide additional benefits over existing treatments. US biotech company Intra-Cellular Therapies says it could file its lead drug lumateperone for schizophrenia as early as next year after ... Intra-Cellular maintains this

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics